Dermatology News

Dermatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Marazza G et al. - This is the first comprehensive prospective study analysing the incidence of autoimmune bullous diseases in an entire country. This patient cohort is large enough to establish BP as the most frequent autoimmune bullous disease. Its incidence rate appears higher compared with other previous studies, most likely because of the demographic characteristics of the Swiss population. Nevertheless, based on its potentially misleading presentations, it is possible that the real incidence rate of BP is still underestimated. Based on its significant incidence in the elderly population, BP should deserve more public health concern.

Related Articles

Eotaxin (CCL11), TARC [thymus and activation-regulated chemokine (CCL17)], MCP-1 (CCL2) and CCR-1, CXCR-1, CXCR-2 expression in dermatitis herpetiformis and bullous pemphigoid
Archives of Medical Science, 11/03/09    Relevance Score: 67%

Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid
Clinical and Experimental Dermatology, 10/26/09    Relevance Score: 67%

Linear immunoglobulin A bullous dermatosis
Expert Review of Dermatology, 10/14/09    Relevance Score: 67%

Circulating IgA and IgE autoantibodies in antilaminin-332 mucous membrane pemphigoid
British Journal of Dermatology, 11/05/09    Relevance Score: 66%

Efficacy of Dapsone in the Treatment of Pemphigus and Pemphigoid: Analysis of Current Data
American Journal of Clinical Dermatology, 10/20/09    Relevance Score: 66%

Today in Autoimmune/Bullous Dz...keeping you current

Hyper IgE syndrome with umbilical hernia
Indian Journal of Dermatology, 11/25/09

Pemphigus vegetans in a patient with colonic cancer
Indian Journal of Dermatology, Venereology and Leprology , 11/19/09

The immunocompromised district: a unifying concept for lymphoedematous, herpes-infected and otherwise damaged sites
Journal of the European Academy of Dermatology and Venereology, 11/16/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address